2.19MMarket Cap-68P/E (TTM)
1.6300High1.4500Low56.79KVolume1.5900Open1.6300Pre Close86.29KTurnover4.94%Turnover RatioLossP/E (Static)1.46MShares13.200052wk High-0.99P/B1.72MFloat Cap1.300052wk Low--Dividend TTM1.15MShs Float2141994.0840Historical High--Div YieldTTM11.04%Amplitude1.3000Historical Low1.5190Avg Price1Lot Size
Cyclacel Pharmaceuticals Stock Forum
Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting
Cyclacel Pharmaceuticals announced preclinical data for fadraciclib, a CDK2/9 inhibitor, demonstrating efficacy in metastatic colorectal cancer (CRC) models. Presented at the 2024 ASCO Annual Meeting, the study showed that fadraciclib significantly inhibited tumor growth, induced apoptosis, and triggered anaphase catastrophe in CRC patie...
📊⚡️📊
👉 GHOST NET - DEMON TRAP - GAI WIX 👈👉 BUYERS MUST SELL ALL AND DELETE NOW👈. 👎THEY BLOCK SHORT + (BID & ASK TOO FAR & UNDER $1 DELETE ), THEY ONLY TRAP STUPID INVESTORS BILLION OF DOLLARS A DAY 🗡👊💣👹💰
(PIK - LPA - DHAC - SMFL - SMMT - SRDX - VSTM - SMR - UVXY - AVTX - BTTR - DXYZ - GNLX - CZOO - MRUS - OKLO - AKAN - SWIN - IGMS - ARRY - MARA - CTNT - GTBP - EDBL - MTC - CAR - ARM - CVNA - SITM - NSP - POWL - AWIN - GME - BIG - BMTX - DXYZ - DOGZ - HOLO - KOSS...
No comment yet